Literature DB >> 15304117

Pancreatic enzyme supplement improves dysmotility in chronic pancreatitis patients.

Takaaki Mizushima1, Koji Ochi, Mitsuko Ichimura, Katsuyuki Kiura, Hideo Harada, Norio Koide.   

Abstract

BACKGROUND AND AIMS: Impaired gallbladder contraction and rapid gastric emptying in patients with chronic pancreatitis may be the result of depleted pancreatic exocrine function. The authors tested whether oral pancreatic enzymes can improve the dysmotility or not.
METHODS: Study subjects consisted of 15 patients with chronic pancreatitis and 18 healthy controls. The gastric emptying time and gallbladder contraction were studied. All patients were initially studied using a test meal without pancreatic enzymes, followed on separate days by a test meal with a single and a triple dose of pancreatic enzymes. Blood samples were taken before and 2 h after the test meal to determine the pancreatic polypeptide levels.
RESULTS: In patients with chronic pancreatitis, gallbladder contraction at 15 min after the meal was impaired. The gastric emptying time was faster and the ratio of pre- to postprandial pancreatic polypeptide levels was enhanced. A single dose and a triple dose of oral enzymes further improved the gastric emptying time and the pancreatic polypeptide ration, but did not improve the gallbladder contraction rate at 15 min.
CONCLUSIONS: It was demonstrated that the oral pancreatic enzymes improved the gastric dysmotility, confirming the previous findings that suggested the depleted pancreatic enzyme output caused the dysmotility. Copyright 2004 Blackwell Publishing Asia Pty Ltd

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15304117     DOI: 10.1111/j.1440-1746.2004.03429.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  3 in total

1.  Regional gastrointestinal transit times in patients with chronic pancreatitis.

Authors:  Isabelle M Larsen; Sidse Holten-Rossing; Esben Bolvig Mark; Jakob Lykke Poulsen; Klaus Krogh; S Mark Scott; Søren Schou Olesen; Asbjørn Mohr Drewes
Journal:  Medicine (Baltimore)       Date:  2022-10-14       Impact factor: 1.817

2.  Enzyme replacement therapy for pancreatic insufficiency: present and future.

Authors:  Aaron Fieker; Jessica Philpott; Martine Armand
Journal:  Clin Exp Gastroenterol       Date:  2011-05-04

3.  Delayed release pancrelipase for treatment of pancreatic exocrine insufficiency associated with chronic pancreatitis.

Authors:  Devi Mukkai Krishnamurty; Atoosa Rabiee; Sanjay B Jagannath; Dana K Andersen
Journal:  Ther Clin Risk Manag       Date:  2009-07-12       Impact factor: 2.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.